• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/13

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

13 Cards in this Set

  • Front
  • Back
Symptomatic Bradycardia
If the patient is symptomatic (light headed, decreased BP, decreased U. O)
Give Atropine IV 0.5mg to 1.0 mg until a maximum of 3.0 mg have been given
Consider transcutaneous pacing
May need sedation
Dopamine infusion at 5-10 mcg/kg/min
Pulseless Electrical Activity (PEA)
Epinephrine 1mg IVP (Epinephrine may be repeated every 3-5 minutes)
Atropine 1 mg IV (may repeat in 3-5 minutes until a total of 0.04 mg/kg is given)
Treat cause (5 H’s and 5 T’s)
Asystole
Consider transcutaneous pacemaker – last resort
Epinephrine
Atropine
Epinephrine
IV dose: 1 mg (10cc of 1:10,000 solution administer every 3-5 minutes during resuscitation. Follow each dose with 20 cc of IV flush. May repeat often
Continuous infusion: Add 30 mg epinephrine (30cc of 1:1000 solution) to 250 cc of NS or D5W and run at 100 cc/hr to titrate to the desired effect. Infuse on an infusion pump
ET tube route: 2.0-2.5 mg diluted in 10 cc of NS.
Atropine
Asystole or PEA: 1mg IV push. May repeat in 3-5 minutes for a maximum dose of 0.03-0.04mg/kg
Bradycardia: 0.5-1.0mg IV every 3-5 minutes, not to exceed total dose of 0.04mg/kg (or about 3 mg)
ET tube administration: 2-3 mg diluted in 10 cc NS. Instilled into the ET followed by several quick ventilations
Amiodarone
In pulseless VTach/VFib- 300mg IV- May repeat at 150mg x 1 followed by drip as below
For VTach with pulse, other tachydysrhythmias:
Initially the patient will receive 150 mg IV over 10 minutes (dilute 150 mg in 100cc of solution).
Then using the concentration (900mg in 500cc solution) infuse 1 mg/min for 6 hours.
Followed by a continuous infusion 0.5 mg/min via an infusion pump
Lidocaine
Initial dose: 1.0-1.5 mg/kg IV. May repeat in 3-5 minutes at half the dose until a maximum dose of 3 mg/kg has been reached.
Infusion: 1-4 mg/min
ET administration: 2-4 mg/kg
Dopamine
Low doses-0.5-2 mcg/kg/min-produces a vasodilating effect on the renal, mesenteric and cerebral arteries. Urinary output increases while HR and BP stay the same
Doses of 2-10 mcg/kg/min-produces beta effects which increases cardiac output due to enhanced myocardial contractility
Higher doses-above 10-20 mcg/kg/min-produces alpha effects which cause vasoconstriction

Should not be added to solutions containing sodium bicarbonate since dopamine is inactivated in an alkaline pH
Diltiazem (Cardiazem)
Useful in PSVT, especially associated with atrial fibrillation or flutter
IV bolus (0.25mg/kg) followed by infusion (5-15mg/hr).
Magnesium
Refractory Ventricular Fibillation - reoccurring
Torsades de Pointes (type of Ventricular tachycardia)
Known deficiency
IV bolus followed by infusion titrated by magnesium levels
Norepinephrine (Levophed)
Vasopressor
Continuous infusion of 0.5 to 20mcg/min
Very potent, can cause loss of digits
Calcium Chloride
Underlying problem
Hypocalcemia
Hyperkalemia
Calcium channel blocker toxicity
Morphine
Ischemic chest pain
Pulmonary edema
Increases venous capitance